LYNDELL LOMAX: Open Payments
NPI 1639560410 · PITTSFIELD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$310 in 18 payments from 9 companies in 2025. Trend: 2023 $167 · 2024 $45 · 2025 $310
Food & beverage: $310
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $109 |
| Amgen Inc. | 3 | $49 |
| ABBVIE INC. | 2 | $37 |
| Neurocrine BioSciences, Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Lundbeck LLC | 1 | $14 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $12 |
Products named: REXULTI, REPATHA, ABILIFY MAINTENA, VRAYLAR, INGREZZA, Auvelity, FANAPT, CAPLYTA.
Industry payments across IL — which companies pay providers there.
